Suscribirse

Impact of IT-enabled Intervention on MRI Use for Back Pain - 22/05/14

Doi : 10.1016/j.amjmed.2014.01.024 
Ivan K. Ip, MD, MPH a, b, c, d, , Esteban F. Gershanik, MD, MPH, MMSc a, b, c, d, Louise I. Schneider, MD a, b, c, d, Ali S. Raja, MD, MPH, MBA a, b, d, e, Wenhong Mar, MSc a, b, Steven Seltzer, MD b, d, Michael J. Healey, MD c, d, f, Ramin Khorasani, MD, MPH a, b, d
a Center for Evidence-Based Imaging, Harvard Medical School, Boston, Mass 
b Department of Radiology, Harvard Medical School, Boston, Mass 
c Department of Medicine, Harvard Medical School, Boston, Mass 
d Brigham and Women's Hospital, Harvard Medical School, Boston, Mass 
e Department of Emergency Medicine, Harvard Medical School, Boston, Mass 
f Brigham and Women's Physician Organization, Harvard Medical School, Boston, Mass 

Requests for reprints should be addressed to Ivan K. Ip, MD, MPH, Center for Evidence-Based Imaging, Department of Radiology and Medicine, Brigham and Women's Hospital, 20 Kent Street, 2nd floor, Boston, MA 02120.

Abstract

Background

The purpose of this study was to examine the impact of a multifaceted, clinical decision support (CDS)-enabled intervention on magnetic resonance imaging (MRI) use in adult primary care patients with low back pain.

Methods

After a baseline observation period, we implemented a CDS targeting lumbar-spine MRI use in primary care patients with low back pain through our computerized physician order entry, as well as 2 accountability tools: mandatory peer-to-peer consultation when test utility was uncertain and quarterly practice pattern variation reports to providers. Our primary outcome measure was rate of lumbar-spine MRI use. Secondary measures included utilization of MRI of any body part, comparing it with that of a concurrent national comparison, as well as proportion of lumbar-spine MRI performed in the study cohort that was adherent to evidence-based guideline. Chi-squared, t-tests, and logistic regression were used to assess pre- and postintervention differences.

Results

In the study cohort preintervention, 5.3% of low back pain-related primary care visits resulted in lumbar-spine MRI, compared with 3.7% of visits postintervention (P <.0001, adjusted odds ratio 0.68). There was a 30.8% relative decrease (6.5% vs 4.5%, P <.0001, adjusted odds ratio 0.67) in the use of MRI of any body part by the primary care providers in the study cohort. This difference was not detected in the control cohort (5.6% vs 5.3%, P = .712). In the study cohort, adherence to evidence-based guideline in the use of lumbar-spine MRI increased from 78% to 96% (P = .0002).

Conclusions

CDS and associated accountability tools may reduce potentially inappropriate imaging in patients with low back pain.

El texto completo de este artículo está disponible en PDF.

Keywords : Clinical decision support, Health information technology, Imaging use


Esquema


 Funding: This study was funded in part by Grant 1UC4EB012952-01 from the National Institute of Biomedical Imaging and Bioengineering.
 Conflict of Interest: RK is a consultant to Medicalis Corporation. RK is named on US Patent 6,029,138 held by Brigham and Women's Hospital on Clinical Decision Support-related software licensed to Medicalis Corporation in the year 2000. As the result of this licensing, Brigham and Women's Hospital and its parent organization, Partners Healthcare Inc., have equity and royalty interests in Medicalis. SS is President of Brigham Radiology Research and Education Foundation, which has been an equity holder in Medicalis Corporation. SS has been the recipient of research grants from Siemens, GE, and Toshiba, and is on the Board of Directors of the Association of University Radiologists, Society of Chairs of Academic Radiology Departments, and the Academy of Radiology Research. EFG is a stockholder in Amgen, Eli Lilly and Company, General Electric Company, Johnson & Johnson, and Pfizer, Inc.
 Authorship: All authors had access to the data and played a role in writing the manuscript.


© 2014  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 127 - N° 6

P. 512 - juin 2014 Regresar al número
Artículo precedente Artículo precedente
  • Beta-blocker Use in ST-segment Elevation Myocardial Infarction in the Reperfusion Era (GRACE)
  • Kay Lee Park, Robert J. Goldberg, Frederick A. Anderson, José López-Sendón, Gilles Montalescot, David Brieger, Kim A. Eagle, Allison Wyman, Joel M. Gore, Global Registry of Acute Coronary Events Investigators
| Artículo siguiente Artículo siguiente
  • ‘Real-World’ Antithrombotic Treatment in Atrial Fibrillation: The EORP-AF Pilot Survey
  • Gregory Y.H. Lip, Cécile Laroche, Gheorghe-Andrei Dan, Massimo Santini, Zbigniew Kalarus, Lars Hvilsted Rasmussen, Popescu Mircea Ioachim, Otilia Tica, Giuseppe Boriani, Paolo Cimaglia, Igor Diemberger, Camilla Fragtrup Hellum, Bettina Mortensen, Aldo P. Maggioni

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.